2023-08-31 21:00:15
Over the years, attempts have been made to understand the link between the human body and its microbiome, and little by little a communication mechanism between gut bacteria and the brain has been revealed.
In medical terms, this relationship is established through chemical molecules (neurotransmitters) that are known or are often heard by the public, such as serotonin, dopamine GABA3, which are produced by intestinal bacteria. And while these molecules can’t cross the blood-brain barrier that protects the brain, their influence spreads through an ingenious messaging system.
What role does marketing play in this context?
The pharma marketing approach has found an opportunity for research in gut-brain communication. The understanding that microbial neurotransmitters can act on cells in the intestinal wall, relaying their message to the central nervous system via neurons in the digestive tract, presents exciting opportunities to develop innovative drug therapies.
These advances can influence mental and emotional health, through interventions that directly affect gut bacteria.
However, one of the most important challenges of pharma marketing addresses the ethical issue that responds: how to translate these scientific advances into effective and safe therapeutic solutions?
Tailoring treatments based on individual microbiome composition, promoting targeted nutritional supplements, and developing drugs designed to interact with gut bacteria are some of the areas where significant impact can be made.
Therefore, the discovery of communication between gut bacteria and the brain has opened up a new dimension in medical research and pharmaceutical marketing. As other aspects of this interaction are discovered, the pharma industry is in a unique position to develop interventions that address not only physical challenges, but also emotional and mental ones, thus contributing to a comprehensive approach to patient health.
References:
Héctor Salinas is a graduate of CECC Pedregal with a degree in Marketing and Advertising. He has more than 10 years of experience in the pharma industry for the development of campaigns and special projects for the main pharmaceutical companies worldwide. He is currently CEO of McCANN Health – Integral Systems. AN IPG Health Company, a leading agency in the pharmaceutical field with products and brands that have leaders in the health market.
#Pharmaceutical #marketing #GutBrain #communication